Showing results (321-330 of 444) with videos related to

Sort By:
Pageof 45
Respiratory Medicine|January 23, 2019
Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosisKevin K Brown, Kevin R Flaherty, Vincent Cottin, et al.
Respiratory Research|September 28, 2024
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal studyGiacomo Sgalla, Jacopo Simonetti, Arianna Di Bartolomeo, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b studySteven D Nathan, Jürgen Behr, Harold R Collard, et al.
Chest|June 21, 2017
Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL ModelJulie Morisset, Eric Vittinghoff, Brett M Elicker, et al.
Chest|March 5, 2014
A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung diseaseTracy J Doyle, Joyce S Lee, Paul F Dellaripa, et al.
BMC Medicine|November 11, 2015
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatmentsSara De Biasi, Stefania Cerri, Elena Bianchini, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Viral infection in acute exacerbation of idiopathic pulmonary fibrosisSharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh, et al.
Thorax|January 14, 2017
The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumoniaRobert Brownell, Teng Moua, Travis S Henry, et al.
JAMA|May 19, 2024
Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical TrialGanesh Raghu, Luca Richeldi, Evans R Fernández Pérez, et al.
Frontiers in Medicine|June 27, 2022
Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio RegionRossella Di Bidino, Paola Rogliani, Alfredo Sebastiani, et al.
Pageof 45